Objective-In resistance arteries, endothelial cell (EC) extensions can make contact with smooth muscle cells, forming myoendothelial junction at holes in the internal elastic lamina (HIEL). At these HIEL, calcium signaling is tightly regulated. Because Calr (calreticulin) can buffer ≈50% of endoplasmic reticulum calcium and is expressed throughout IEL holes in small arteries, the only place where myoendothelial junctions form, we investigated the effect of EC-specific Calr deletion on calcium signaling and vascular function. Approach and Results-We found Calr expressed in nearly every IEL hole in third-order mesenteric arteries, but not other ER markers. Because of this, we generated an EC-specific, tamoxifen inducible, Calr knockout mouse (EC Calr Δ/Δ).
M aintenance of normal blood pressure relies on a balance of small diameter artery constriction and dilation that contributes to peripheral vascular resistance. 1 Receptormediated signaling that occurs within endothelial cells (ECs) and smooth muscle cells (SMCs) is particularly key to vascular tone regulation. 2, 3 Any perturbation in these signaling processes in resistance arteries can shift blood pressure away from homeostasis and toward hypertension. 4, 5 Calcium is a tightly regulated signaling molecule in the vascular wall with cytosolic increases having opposing effects on vascular tone. 6 Unstimulated cells maintain cytosolic calcium at nanomolar levels, thus increases in EC cytosolic calcium result in vasodilation; increased SMC cytosolic calcium results in vasoconstriction. However, increases in SMC calcium and inositol 1,4,5 trisphosphate (IP 3 ) via α1D-adrenergic receptor stimulation with PE (phenylephrine) have been shown to elicit subsequent increases in EC calcium, [7] [8] [9] indicating that heterocellular communication occurs between the 2 cell types. In resistance arteries, direct cytoplasmic contact between EC and SMC can occur via cellular projections through holes in the internal elastic lamina (HIEL), resulting in the formation of a myoendothelial junction (MEJ). 10, 11 The MEJ predominantly originates from the EC, where focal increases in intracellular calcium occur, activating a well-established signaling cascade, resulting in vasodilation or initiation of negative feedback mechanisms after vasoconstriction. 7, [12] [13] [14] [15] [16] [17] [18] In particular, endoplasmic reticulum (ER)-based calcium signals can occur via IP 3 receptors on the ER that are present within or close proximity to the MEJs. the role of ER calcium release in this signaling cascade is still unclear, due primarily to the inability to specifically manipulate ER-based proteins in vivo.
Calr (calreticulin), well-known for sequestering ER calcium within the ER lumen, 20, 21 was shown by our laboratory to be highly expressed at the MEJ in vitro. 22, 23 In experiments focused on Calr cell biology, the knockdown or overexpression of Calr has profound effects on ER calcium; deletion results in reduced ER calcium and overexpression increases ER calcium. [24] [25] [26] Furthermore, Calr deficient cells have impairments in IP 3 stimulated calcium mobilization. [27] [28] [29] Until now, the role of Calr in the context of vascular tone has not been investigated. In this study, to avoid issues with Calr mediation of organogenesis during development, 27, 30, 31 we used a novel mouse model in which we could reliably induce the deletion of Calr specifically in the endothelium. Given the effects of Calr on ER calcium and ER calcium release in vitro, we predicted we would see similar impairments in IP 3 mediated signaling and hypothesized this would result in changes in calcium signaling, vascular tone, and blood pressure.
Surprisingly, we found that Calr localized to MEJs is unique compared with the Calr in the EC monolayer of intact resistance arteries, and EC deletion of Calr results in a differential response to IP 3 stimulation depending on receptor activation. This alteration in signaling affects vascular tone and blood pressure. Importantly, we show that this polarization of response is likely not because of differences in ER calcium content and may instead be because of MEJ Calr localization outside the ER.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

Calr Is Enriched at HIEL
We investigated the expression of various ER-localized proteins in the context of expression at HIEL. Calnexin ( Figure 1A ) and ERp29 ( Figure 1B) were throughout the EC monolayer ( Figure 1G ), but less so (≈30%) within HIEL, the only place where MEJs form. However, Calr was present in EC monolayers and nearly all the HIEL ( Figure 1C ). Preincubation with Calr peptide before immunofluorescence with the Calr antibody, secondary antibody alone and IgG negative controls could not detect any positive staining ( Figure 1D through 1F) . Quantification of positive Calr staining was found in >80% of the HIEL ( Figure 1H ). We used immuno-electron microscopy and confirmed Calr expression in EC monolayer and MEJs ( Figure 
Generation of Tamoxifen Inducible, Endothelial-Specific, Calr Knockout Mouse
Because Calr is expressed in ECs and within MEJs, and ER calcium could be an important regulator of vascular function, we hypothesized that EC deletion of Calr could alter heterocellular calcium signaling. For these reasons, we made a tamoxifen inducible, EC-specific, Calr knockout mouse (EC Calr Δ/Δ; Figure 2A ). To check the efficiency of Calr knockout, we used primers designed to detect the truncated Calr gene, with a size of ≈400 bp only seen in EC Calr Δ/Δ mice 30 ( Figure 2B ). Third order mesenteric arteries from these mice were stained for Calr ( Figure 2C ; Figures III and IV in the online-only Data Supplement), and a significant reduction in Calr at HIEL was identified in EC Calr Δ/Δ mice ( Figure 2D ). To more specifically look at EC Calr expression, we isolated microvascular diaphragm ECs and found EC Calr Δ/Δ mice had significantly fewer double positive cells (CD31+/Calr+ cells; Figure 2E ; Figure 
Calcium Events in EC Monolayer and HIEL of EC Calr Δ/Δ Arteries
To investigate the physiological effect of EC Calr knockout, a muscarinic agonist (CCh [carbachol] ) and an adrenergic agonist (PE) were used because of their ability to activate calcium events at HIEL ( Figure 3A ; Figure VIII in the onlineonly Data Supplement). When we focused on calcium events occurring in the endothelium specifically at HIEL ( Figure 3B and 3C), CCh significantly increased calcium events at HIEL in both the EC Calr fl/fl and EC Calr Δ/Δ arteries ( Figure 3D and 3E). Addition of PE to the arteries caused a significant increase in EC Calr fl/fl calcium events, however EC Calr Δ/Δ arteries did not exhibit this same increase ( Figure 3F and 3G ). There was no difference in the PE calcium response in SMC ( Figure IX in the online-only Data Supplement).
Calcium events also occur outside of the HIEL in the rest of the EC (EC monolayer). CCh stimulation caused a significant increase in calcium events in the EC monolayer in both EC Calr fl/fl and Δ/Δ mice (Figure X in the online-only Data Supplement). PE application had no effect on calcium events in the EC monolayer ( Figure X in the online-only Data Supplement), indicating that PE can only stimulate calcium events within the holes of the IEL. Thus, EC Calr Δ/Δ arteries are able to significantly increase calcium events in response to CCh, but not PE, and these differences occur at the HIEL. 
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Constriction and Dilation of EC Calr Δ/Δ Arteries
Because localized calcium events in the HIEL activate signaling cascades that affect vascular contractility, 12,16 the effect of EC Calr Δ/Δ on dilation to CCh and constriction to PE was investigated. In line with our calcium data, dilation to CCh over a range of concentrations was not different between groups ( Figure 4A ). However, EC Calr Δ/Δ arteries constricted significantly more to PE than to control ( Figure 4B ), functional evidence that correlates with their failure to increase calcium events in response to PE. This is likely not because of alteration of intrinsic SMC signaling as myogenic tone at 80 mm Hg ( Figure 4C Given the calcium imaging and vascular reactivity results, we next investigated whole animal mean arterial pressure via radiotelemetry catheters. Before tamoxifen injection, mean arterial pressure was not different ( Figure 4E , solid bars), but after induction of EC Calr deletion, EC Calr Δ/Δ mice increased their mean arterial pressure relative to each mouse's own preinjection baseline. ( Figure 4F ). The heart rate was not different before or after injection (Figure XIV in the onlineonly Data Supplement).
Calr Does Not Affect the Level of ER Calcium or Expression of ER-Localized Channels
To determine whether the EC Calr deletion was altering the ER calcium, we first incubated arteries with 0 mmol/L extracellular calcium (to prevent extracellular calcium from entering the cell) followed by cyclopiazonic acid (to block sarco-endoplasmic reticulum calcium ATPase mediated refilling of the ER). Peak cytosolic calcium, specifically released from the ER, did not show any difference in ER calcium content in the arteries ( Figure 5A ). Next, primary human EC were transfected with GCaMP-ER to specifically visualize ER calcium bound to the low affinity indicator (Figures XV and XVI in the online-only Data Supplement). Cotransfection of human EC with Calr siRNA resulted in a ≈40% decrease in . E, Diaphragm microvasculature was digested, stained for CD31 (EC marker) and Calr, and analyzed via flow cytometry (EC Calr fl/fl, n=6; EC Calr Δ/Δ, n=5). F, HIEL were quantified to approximate the number of myoendothelial junctions (MEJs). Images were from en face arteries using autofluorescence of the IEL (EC Calr fl/fl, n=22 fields of view; EC Calr Δ/Δ, n=19 fields of view). * indicates P<0.05, *** P<0.001. Groups were compared using an unpaired student t test.
Calr protein as measured by Western blot (
Figure 5B), which was concordant with our whole animal knockdown (Figure 2 ). GCaMP-ER fluorescence was measured via flow cytometry in live EC and divided into low, medium, and high fluorescence intensity ( Figure 5C ). There was no difference in the amount of fluorescence between GCaMP alone, GCaMP cotransfected with Calr siRNA, or GCaMP cotransfected with scrambled siRNA ( Figure 5D ). This data coincides with the intact arteries indicating that the knockdown of Calr did not alter free ER Ca 2+ levels. Furthermore, we investigated IP3R and sarco-endoplasmic reticulum calcium ATPase 2 expression and found no significant differences in mRNA levels between EC Calr fl/fl and Δ/Δ arteries ( Figure XVII in the online-only Data Supplement).
Subcellular Localization of Calr in the MEJ
Because of the lack of changes in total ER calcium content, we further hypothesized that the Calr at the HIEL and MEJ may be regulating ER calcium signals independently of its calcium buffer function within the ER. To determine whether Calr at HIEL was different from the Calr in the EC monolayer, we used proximity ligation assay; the protein ERp57 is a widely recognized binding partner of ER-localized Calr. 32 We found association of the 2 proteins throughout the EC monolayer of arteries, but few in the HIEL ( Figure XVIII in the online-only Data Supplement). Next, using digitonin to selectively permeabilize the plasma membrane (but not ER 33, 34 ), we repeated the en face immunofluorescence for calnexin ( Figure 6A ), ERp29 ( Figure 6B ), and Calr ( Figure 6C ) in wild-type mouse mesenteric arteries. In both and drug values were compared using a paired student t test, whereas EC Calr fl/fl and EC Calr Δ/Δ changes were compared using an unpaired student t test. SMC indicates smooth muscle cell.
the EC monolayer and the HIEL, there was no signal for calnexin and ERp29 ( Figure 6D and 6E) . The Calr staining exhibited strong punctate signal in the HIEL ( Figure 6E ). In contrast to the rigorous permeabilization of Triton X-100, which permeabilizes all membranes, digitonin preferentially permeabilizes the plasma membrane but not the ER membrane. Thus, incubation with digitonin resulted in no observable staining in the EC monolayer ( Figure 6D ). This was seen with all of the ER markers, including Calr. Next, we attempted to inhibit Calr expression at HIEL. Because Calr in the cytosol is derived from the ER 35 and could be trafficked out of the ER, 36 we incubated arteries with brefeldin A, which inhibits anterograde traffic out of the ER. This treatment caused a significant decrease in the Calr fluorescence in HIEL, but not the EC monolayer ( Figure 6F through 6H). Further evidence of Calr polarization of function was found from immunoprecipitated calreticulin in vascular cell cocultures, which demonstrated selective binding to binding immunoglobulin protein (glucose regulated protein 78/BiP) in EC monolayers (an ER chaperone protein), and binding to thrombospondin-1 in the MEJ fractions (an association found outside of the ER; Figure XIX in the online-only Data Supplement). This data suggest that the Calr in endothelial monolayers of arteries is found in the ER, but the Calr at HIEL may not be ER-based.
Discussion
In ≈30% of HIEL, we observed all 3 well-established markers for the ER, which indicate the presence of ER at the MEJ in some instances. This finding is consistent in the literature. 17, 19 However, the fact that Calr was found in nearly every hole in the IEL (≈80%) was unexpected and markedly different than the other ER markers. The permeabilization of arteries with digitonin and the inhibition of Calr transfer to HIEL with brefeldin A further suggest that the pool of Calr found in nearly every hole in the IEL of the arteries was not ER-based and could be indicative of a functionally unique pool of Calr. Our evidence in EC Calr Δ/Δ mice confirms this; in third-order mesenteric arteries, the ECs no longer respond with increases in calcium after SMC stimulation (but there is no impairment in the response to muscarinic stimulation) and pressurized arteries are more reactive to PE (but there is no impairment in the response to muscarinic dilation). In addition, the mice have an increase in mean arterial pressure. This phenotype occurred despite no evident change in global ER calcium in the ECs. The sum of the evidence seems to indicate that non-ER based Calr in the holes of the IEL of mesenteric arteries is an important, and unexpected, component to regulating negative feedback from smooth muscle to endothelium.
The finding that traditional ER markers are not expressed in the majority of IEL holes was also surprising. Although we use IEL holes as a surrogate for MEJ expression and they are the only place where MEJ form, not every IEL hole contains a corresponding functional MEJ. 37 Previous research using en face immunofluorescence has shown that calnexin in mouse mesenteric arteries is present in IEL holes, 15 but there was no quantification or data from multiple fields of view to know if the proportion of expression in IEL holes was similar to our results. Although the ER is a continuous compartment, it could be possible that calnexin and ERp29 are differentially segregated to areas of the ER separate from Calr. The data presented here now suggest there may also be a population of IEL holes that do not exhibit the presence of ER, which lends support to the conclusion that Calr may be mediating heterocellular signaling from outside the ER.
Because global Calr deletion in mice is embryonically lethal at E14 27 and there is sparse evidence on cell specific Calr knockout mice, 30, 38 we have no direct comparison to our knockout efficiency in vivo. Other researchers have attempted to knockout Calr in ECs and achieved only ≈50% decreases in protein in vitro. 39 Using the same Calr fl/fl mouse (but without the Cre recombinase), Zimmerman et al 38 reported a knockout efficiency of 60% in SMC transfected with Cre-recombinase IRES-GFP (internal ribosome entry site-green fluorescent protein). This may be because the half-life of Calr was calculated to be 4.5 days in an untreated HL-60 (human promyelocytic leukemia cells) cell line. These same authors also noted that Calr proved to be an exceedingly stable protein. 40 It is likely we have achieved maximal knockout in our models, and further research into Calr may explain why it is so difficult to achieve >60% deletion in vivo and in vitro. Nevertheless, we see significant differences in physiology using a mouse model with significant but not complete deletion of EC Calr. This has allowed us to dissect out a differential role for Calr at the MEJ versus Calr in the rest of the EC.
Smaller, more localized changes in ER calcium or compensatory increases in calcium influx (independent of TRPV4) in the EC cannot be ruled out in EC Calr Δ/Δ arteries. However, our evidence does not show any significant differences in ER calcium within the mesenteric arteries or in human ECs transfected with GCaMP-ER. These findings correspond to data from other groups that have shown Calr deletion or knockdown does not affect IP 3 mediated calcium stores. 41 In their experiments, both resting and stimulated conditions did not change calcium levels in embryonic stem cells with or without Calr. 41 The lack of difference between the groups in their calcium signaling and dilation to CCh supports the finding that ER calcium is not globally changed in our model. However, altering EC calcium mobilization has been shown to increase constriction to PE, 19 which is consistent with our results in isolated mesenteric arteries. Vascular responses such as basal myogenic tone at 80 mm Hg and direct activation of endothelial and MEJ-localized calcium-activated potassium channels with NS309 indicated intact MEJ signaling and endothelial integrity in both groups. This confirms that the differential response to PE is not simply because of an experimental artifact. One possible explanation for our results is the role of non-ER based Calr as a mediator of integrin-based cell adhesion. There is strong evidence that indicates there is a calcium-dependent interaction between Calr and the cytoplasmic tail of alpha integrin. 42, 43 Calr downregulation in cells decreases their adhesive capacity and migration 31, 39, 41, 44 and some of these effects may be mediated by c-Src and calciumcalmodulin kinase II signaling. 45, 46 Furthermore, overexpression studies have also shown alterations in adhesion. 47 This would be important in terms of resistance arteries as the EC and MEJ must be coupled to the SMC to receive the PE signal. 48 Knockout of Calr has been shown to inhibit attachment to the extracellular matrix 43 and downregulate cell adhesion related genes. 49 One of the upregulated genes was Notch1, which has been shown to induce SMC adhesion to the EC basement membrane via integrin signaling. 50 Our results show no changes in IEL hole number in our arteries, but elucidation of adhesion mechanisms could be more sophisticated than simply changing the hole formation. Cell adhesion at the MEJ, in addition to integrin expression and function, has not been characterized. This is an intriguing future direction of exploration, particularly in the context of resistance artery function and control of blood pressure.
Beyond its role in cell adhesion and migration, Calr can be a major ER chaperone, key in maintaining proper protein folding, a calcium-dependent process. 51 The knockdown of Calr protein has been shown by multiple groups to induce ER stress. [52] [53] [54] There is evidence that ER stress via tunicamycin causes endothelial dysfunction by decreased eNOS phosphorylation. 55 Furthermore, ER stress inhibition in angiotensin II-induced hypertension improved vascular reactivity in mesenteric arteries. 56 We cannot exclude ER stress in our mouse model, especially in polarization of calcium responses and reactivity. However, we note several observations in the EC that lead us to conclude that uncontrolled ER stress may not be occurring in our model. These include the intact CCh calcium responses and vasodilation, as well as the undiminished responses to calcium-activated potassium channels with NS309. In both cases, significant ER stress would be expected to alter these fundamental vascular responses. Based on the evidence of Calr localization at the MEJ, it seems unlikely that Calr is acting as an ER chaperone at the MEJ. This may be more likely in the EC monolayer, as we see a greater interaction with GRP78/BiP (in vitro) and ERp57 (en face arteries) versus at the MEJ/in the holes of the IEL. It is also possible that our induction of Calr deletion post development (at 6 weeks of age) and without a concomitant pathological situation does not induce an ER stress response.
Calr has been reported in many subcellular compartments beyond the ER depending on the cell type, pathological condition, and context that is investigated. 57 Our data demonstrate differences between Calr in the EC monolayer, which is perinuclear with typical ER-like staining, and the IEL holes, which have strong punctate staining. When the arteries are permeabilized with digitonin and not Triton, the typical EC monolayer staining is not visible, whereas the MEJ Calr remains similar ( Figure 6 ). Because digitonin is a mild, non-ionic detergent that preferentially interacts with cholesterol, it does not permeabilize intracellular membranes such as the mitochondrial, lysosomal, nuclear, or importantly, the ER membrane. 33, 34 Some evidence suggests that Calr is the only ER-based mammalian protein able to retrotranslocate out of the ER independently of a protein degradation signal. 35 Exactly how Calr is mediating calcium signaling outside of the ER at the MEJ may become evident by looking at downstream signaling targets.
The movement of IP 3 from SMCs to ECs through gap junctions has been established, 9, 13, 15, 19 however, we cannot rule out the role of calcium also moving from smooth muscle to endothelium. 13, 58 Although the type of second messenger moving between cells was not the focus of the study, our use of nifedipine to close L-type calcium channels (used experimentally to limit movement of the artery on the microscope) focus the smooth muscle to endothelial calcium events more specifically on IP 3 . In this way, we can speculate there is a role for Calr affecting calcium release from IP 3 receptors. There is evidence for this in the literature, where decreased Calr can upregulate CaMKII (calcium/calmodulin-dependent kinase II) activity, 46 and active CaMKII can inhibit IP 3 receptor-mediated calcium release at HIEL. 17 If Ca 2+ can also move from smooth muscle to endothelium as part of the heterocellular signaling process, it would be interesting to speculate how calcium and IP 3 may interact with, or be influenced by Calr, to discretely regulate the calcium events at the HIEL.
In conclusion, we have identified and characterized a non-ER pool of Calr in resistance arteries, found almost exclusively in the holes of IEL. This non-ER pool of Calr can influence heterocellular calcium signaling, vasoreactivity, and physiological blood pressure control. The data suggest that modulating Calr expression or its protein interactions outside of the ER may prove to be a viable target for antihypertensive therapy.
